host

Yonsei University to Host GEEF 2025, Exploring Innovative Solutions for the SDGsYonsei University to Host GEEF 2025, Exploring Innovative Solutions for the SDGs

Yonsei University to Host GEEF 2025, Exploring Innovative Solutions for the SDGs

GEEF 2025 will take place on March 13–14, bringing together 83 speakers from 14 countries to discuss solutions for bridging…

4 days ago
Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ETBetter Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 p.m. ET

March 07, 2025 17:30 ET  | Source: Better Choice Company Inc. TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Better…

5 days ago
Global-e to Host 2025 Investor DayGlobal-e to Host 2025 Investor Day

Global-e to Host 2025 Investor Day

March 06, 2025 16:05 ET  | Source: Global-e Online Ltd PETAH-TIKVA, Israel, March 06, 2025 (GLOBE NEWSWIRE) -- Global-e (Nasdaq:…

1 week ago
CEPT University to Host Urban Planning Masterclass in New Delhi on March 11 & 12CEPT University to Host Urban Planning Masterclass in New Delhi on March 11 & 12

CEPT University to Host Urban Planning Masterclass in New Delhi on March 11 & 12

AHMEDABAD, India, March 4, 2025 /PRNewswire/ -- CEPT University will host a three-part masterclass series on critical aspects of urban…

1 week ago
Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

SAN FRANCISCO and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

2 weeks ago
Toronto to Host EmpowerHER Womens Health Summit on March 1, 2025: Uniting Top Experts for Transformative ChangeToronto to Host EmpowerHER Womens Health Summit on March 1, 2025: Uniting Top Experts for Transformative Change

Toronto to Host EmpowerHER Womens Health Summit on March 1, 2025: Uniting Top Experts for Transformative Change

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The 1st Annual EmpowerHER Women’s Health Summit, hosted by Bridge Medical Communications, will…

2 weeks ago
FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027

FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027

Brazil, Serbia, South Africa, and Uzbekistan in the race to host the global phygital sports event DUBAI, UAE, Feb. 25,…

3 weeks ago
Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)

February 18, 2025 16:30 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) --…

3 weeks ago
AVITA Medical to Host Investor Webinar BriefingAVITA Medical to Host Investor Webinar Briefing

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound…

4 weeks ago
ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

MELBOURNE, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers…

1 month ago
Show more Posts